Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Supreme Cannabis Company Inc. (The) T.FIRE

The Supreme Cannabis Co Inc is a Canada-based company engaged in the production and sale of medical and recreational cannabis. Its portfolio includes products that address recreational, medical, and wellness consumers. Its brands include BlissCo, Truverra, 7ACRES, Sugarleaf, and Hiway.


TSX:FIRE - Post by User

Comment by ediabidon Mar 14, 2020 12:27pm
74 Views
Post# 30807682

RE:RE:News

RE:RE:News
Dunworkin2 wrote: Can you share the link or source for the approval of the additional grow rooms from HC, thanks.


 
 

Supreme Cannabis’ 7ACRES Facility is Fully Licensed.


This week, Supreme Cannabis’ 7ACRES facility in Kincardine, Ontario received licensing approval from Health Canada for multiple secure storage rooms, processing rooms and grow rooms. As announced on February 13th, subsequent to completion of final construction at 7ACRES, the Company submitted licence approval to Health Canada for an additional 20,000 square feet of flowering space and 10,000 square feet of vegetation and propagation space. With receipt of these licenses, the company expects to bring the additional 30,000 square feet of cultivation space online prior to the end of March, bringing total flowering, vegetation and propagation space to 280,000 square feet.

In addition to cultivation space, 7ACRES received licensing for four processing rooms, one laboratory and three additional secured storage areas. Processing space will be dedicated to value-add product manufacturing, final packaging and labeling activities. The licensing of 7ACRES’ laboratory allows for the facility to expand its internal analytical capabilities and allocate additional space to genetics R&D.


With additional operations rooms and cultivation space licensed, the Company looks forward to completing its transition to a consumer facing business and achieving further scaled efficiencies. As announced last quarter, 7ACRES has already realized greater operational efficiencies, improving its throughput trimming rate by 400% and increasing its packaging capacity by 200%.

 

Supreme Cannabis Comments on COVID-19.

“We would like to take this opportunity to reassure our investors and customers that at this time the Company’s in-house operations continue to run smoothly, our facilities maintain a deep inventory of necessary supplies and as of today, our sales pipeline has not been impacted by COVID-19. The health and safety of our employees and the integrity of our product continues to be a top priority. Supreme Cannabis’ existing sanitization and health and safety practices are best in-class and were designed to reduce the spread of any harmful pathogens. The Company’s businesses and operations have contingency plans in place to respond to all scenarios. Our leadership team continues to monitor developments and we remain confident in the Company’s ability to operate effectively through challenging conditions with limited disruption.”

– Colin Moore, Interim President and CEO
 

Investor News

Supreme Cannabis Focuses Organization and Reduces Cost Structure.

Learn More »

Company News

Supreme Cannabis Announces Q2 2020 and Accelerated Revenue Growth.

Read more »

Investor Contact
For more information, contact investor relations at:
ir@supreme.ca or 416.466.6265

<< Previous
Bullboard Posts
Next >>